Second-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian, Fallopian, Or Peritoneal Cancer

Clinical trial NCT00061308 · COMPLETED

Trial details

NCT number: NCT00061308
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Peritoneal Cancer Ovarian Cancer Neoplasms, Ovarian Fallopian Tube Cancer

Start date: 2002-12-01
Primary completion: 2004-09-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.